Gatehouse Bio is a bio-data company in collaboration with AstraZeneca for the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s AI-powered platform. The sRNAlytics platform identifies small RNA (sRNA) signatures in sequencing data and points to molecular pathways that correlate to or potentially drive disease.
David W. Salzman
Documentaries, videos and podcasts
- BiotechnologyBiotechnology in a broad sense includes the use of living systems and organisms, as well as their parts for the development or production of products.
- RNA-based and RNA-targeted therapeuticsRNA-based therapeutics include RNA and oligonucleotide therapeutics that target RNA and proteins. RNA-targeted therapeutics include RNA and oligonucleotide therapeutics as well as small molecule drugs that target RNA.
- Artificial intelligenceTopics related to artificial intelligence.
- COVID-19COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the World Health Organization.